Pregnancy in Parkinson's disease: A review of the literature and a case report
Identifieur interne : 004F18 ( Main/Exploration ); précédent : 004F17; suivant : 004F19Pregnancy in Parkinson's disease: A review of the literature and a case report
Auteurs : Peter Hagell [Suède] ; Per Odin [Allemagne] ; Ellen Vinge [Suède]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-01.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Abnormalities, Drug-Induced, Adjuvants, Pharmaceutic (therapeutic use), Adult, Amantadine (adverse effects), Animal, Animals, Antiparkinson Agents (therapeutic use), Antiparkinson agent, Aromatic Amino Acid Decarboxylase Inhibitors, Benserazide, Benserazide (therapeutic use), Bibliographic survey, Case study, Chemotherapy, Decarboxylase, Dopa decarboxylase inhibitors, Dopamine Agents (therapeutic use), Dopamine agonists, Enzyme Inhibitors (therapeutic use), Enzyme inhibitor, Female, Human, Humans, Levodopa, Levodopa (adverse effects), Mice, Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Pregnancy, Pregnancy Complications (drug therapy), Pregnancy Outcome, Rabbits, Rats, Selegiline, Selegiline (adverse effects), Treatment.
- MESH :
- chemical , adverse effects : Amantadine, Levodopa, Selegiline.
- chemical , therapeutic use : Adjuvants, Pharmaceutic, Antiparkinson Agents, Benserazide, Dopamine Agents, Enzyme Inhibitors.
- drug therapy : Parkinson Disease, Pregnancy Complications.
- Abnormalities, Drug-Induced, Adult, Animals, Aromatic Amino Acid Decarboxylase Inhibitors, Female, Humans, Mice, Pregnancy, Pregnancy Outcome, Rabbits, Rats.
Abstract
Pregnancy is rare in Parkinson's disease (PD). In the literature on studies of antiparkinsonian drugs in animals during pregnancy, there are reports on malformations of the skeletal and circulatory system. However, the majority of studies in animals have not shown any teratogenicity. Amantadine has been teratogenic in rats and selegiline has caused neurochemical and behavioral alterations in rats when coadministered with clorgyline. The published experience with humans consists of 35 pregnancies among 26 women suffering from PD, including this report, and a number of cases treated with antiparkinsonian agents for other reasons. With the exception of the majority of the cases where amantadine was used, complications have been rare. However, there are indications that suggest a possible risk of a woman's parkinsonism worsening in connection with pregnancy. We also report the case of a woman with PD who was treated with L‐dopa‐benserazide during an uncomplicated pregnancy and gave birth to a healthy boy without experiencing any worsening of her PD.
Url:
DOI: 10.1002/mds.870130110
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002A40
- to stream Istex, to step Curation: 002A40
- to stream Istex, to step Checkpoint: 003653
- to stream PubMed, to step Corpus: 004520
- to stream PubMed, to step Curation: 004520
- to stream PubMed, to step Checkpoint: 004354
- to stream Ncbi, to step Merge: 004E65
- to stream Ncbi, to step Curation: 004E65
- to stream Ncbi, to step Checkpoint: 004E65
- to stream Main, to step Merge: 007E30
- to stream PascalFrancis, to step Corpus: 003095
- to stream PascalFrancis, to step Curation: 003729
- to stream PascalFrancis, to step Checkpoint: 002F41
- to stream Main, to step Merge: 008065
- to stream Main, to step Curation: 004F18
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pregnancy in Parkinson's disease: A review of the literature and a case report</title><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name></author><author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name></author><author><name sortKey="Vinge, Ellen" sort="Vinge, Ellen" uniqKey="Vinge E" first="Ellen" last="Vinge">Ellen Vinge</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B289D7D61719B850A3D537468AA8CF3BBB2AE637</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1002/mds.870130110</idno><idno type="url">https://api.istex.fr/document/B289D7D61719B850A3D537468AA8CF3BBB2AE637/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002A40</idno><idno type="wicri:Area/Istex/Curation">002A40</idno><idno type="wicri:Area/Istex/Checkpoint">003653</idno><idno type="wicri:doubleKey">0885-3185:1998:Hagell P:pregnancy:in:parkinson</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:9452323</idno><idno type="wicri:Area/PubMed/Corpus">004520</idno><idno type="wicri:Area/PubMed/Curation">004520</idno><idno type="wicri:Area/PubMed/Checkpoint">004354</idno><idno type="wicri:Area/Ncbi/Merge">004E65</idno><idno type="wicri:Area/Ncbi/Curation">004E65</idno><idno type="wicri:Area/Ncbi/Checkpoint">004E65</idno><idno type="wicri:doubleKey">0885-3185:1998:Hagell P:pregnancy:in:parkinson</idno><idno type="wicri:Area/Main/Merge">007E30</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:98-0080302</idno><idno type="wicri:Area/PascalFrancis/Corpus">003095</idno><idno type="wicri:Area/PascalFrancis/Curation">003729</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002F41</idno><idno type="wicri:doubleKey">0885-3185:1998:Hagell P:pregnancy:in:parkinson</idno><idno type="wicri:Area/Main/Merge">008065</idno><idno type="wicri:Area/Main/Curation">004F18</idno><idno type="wicri:Area/Main/Exploration">004F18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pregnancy in Parkinson's disease: A review of the literature and a case report</title><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Section of Restorative Neurology, Wallenberg Neuroscience Center, University Hospital, Lund</wicri:regionArea><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Medizinische Hochschule Hannover, Hannover</wicri:regionArea><placeName><region type="land" nuts="2">Basse-Saxe</region><settlement type="city">Hanovre</settlement></placeName></affiliation></author><author><name sortKey="Vinge, Ellen" sort="Vinge, Ellen" uniqKey="Vinge E" first="Ellen" last="Vinge">Ellen Vinge</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Clinical Pharmacology, University Hospital, Lund</wicri:regionArea><wicri:noRegion>Lund</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1998-01">1998-01</date><biblScope unit="vol">13</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="34">34</biblScope><biblScope unit="page" to="38">38</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">B289D7D61719B850A3D537468AA8CF3BBB2AE637</idno><idno type="DOI">10.1002/mds.870130110</idno><idno type="ArticleID">MDS870130110</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abnormalities, Drug-Induced</term><term>Adjuvants, Pharmaceutic (therapeutic use)</term><term>Adult</term><term>Amantadine (adverse effects)</term><term>Animal</term><term>Animals</term><term>Antiparkinson Agents (therapeutic use)</term><term>Antiparkinson agent</term><term>Aromatic Amino Acid Decarboxylase Inhibitors</term><term>Benserazide</term><term>Benserazide (therapeutic use)</term><term>Bibliographic survey</term><term>Case study</term><term>Chemotherapy</term><term>Decarboxylase</term><term>Dopa decarboxylase inhibitors</term><term>Dopamine Agents (therapeutic use)</term><term>Dopamine agonists</term><term>Enzyme Inhibitors (therapeutic use)</term><term>Enzyme inhibitor</term><term>Female</term><term>Human</term><term>Humans</term><term>Levodopa</term><term>Levodopa (adverse effects)</term><term>Mice</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Pregnancy</term><term>Pregnancy Complications (drug therapy)</term><term>Pregnancy Outcome</term><term>Rabbits</term><term>Rats</term><term>Selegiline</term><term>Selegiline (adverse effects)</term><term>Treatment</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amantadine</term><term>Levodopa</term><term>Selegiline</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adjuvants, Pharmaceutic</term><term>Antiparkinson Agents</term><term>Benserazide</term><term>Dopamine Agents</term><term>Enzyme Inhibitors</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term><term>Pregnancy Complications</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Abnormalities, Drug-Induced</term><term>Adult</term><term>Animals</term><term>Aromatic Amino Acid Decarboxylase Inhibitors</term><term>Female</term><term>Humans</term><term>Mice</term><term>Pregnancy</term><term>Pregnancy Outcome</term><term>Rabbits</term><term>Rats</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Animal</term><term>Antiparkinsonien</term><term>Bensérazide</term><term>Chimiothérapie</term><term>Decarboxylase</term><term>Etude cas</term><term>Gestation</term><term>Homme</term><term>Inhibiteur enzyme</term><term>Lévodopa</term><term>Parkinson maladie</term><term>Synthèse bibliographique</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pregnancy is rare in Parkinson's disease (PD). In the literature on studies of antiparkinsonian drugs in animals during pregnancy, there are reports on malformations of the skeletal and circulatory system. However, the majority of studies in animals have not shown any teratogenicity. Amantadine has been teratogenic in rats and selegiline has caused neurochemical and behavioral alterations in rats when coadministered with clorgyline. The published experience with humans consists of 35 pregnancies among 26 women suffering from PD, including this report, and a number of cases treated with antiparkinsonian agents for other reasons. With the exception of the majority of the cases where amantadine was used, complications have been rare. However, there are indications that suggest a possible risk of a woman's parkinsonism worsening in connection with pregnancy. We also report the case of a woman with PD who was treated with L‐dopa‐benserazide during an uncomplicated pregnancy and gave birth to a healthy boy without experiencing any worsening of her PD.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Suède</li></country><region><li>Basse-Saxe</li></region><settlement><li>Hanovre</li></settlement></list><tree><country name="Suède"><noRegion><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name></noRegion><name sortKey="Vinge, Ellen" sort="Vinge, Ellen" uniqKey="Vinge E" first="Ellen" last="Vinge">Ellen Vinge</name></country><country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004F18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B289D7D61719B850A3D537468AA8CF3BBB2AE637
|texte= Pregnancy in Parkinson's disease: A review of the literature and a case report
}}
| This area was generated with Dilib version V0.6.23. |  |